BIOMARKER FOR CORONARY ARTERY DISEASE
    67.
    发明申请

    公开(公告)号:US20180313826A1

    公开(公告)日:2018-11-01

    申请号:US15900680

    申请日:2018-02-20

    Abstract: In various embodiments methods are provided for identifying a mammal having an elevated risk for an adverse cardiac event (e.g. an MI) and/or determining the prognosis for the mammal. In certain embodiments the methods comprise determining, or causing to be determined, the presence and/or level of antibodies that bind a malondialdehyde-acetaldheyde adduct (MAA adduct) in a biological sample from the mammal, where an elevated level of anti-MAA adduct antibodies, as compared to the level found in a normal healthy mammal is an indicator that that said mammal has one or more atherosclerotic lesions and/or is at elevated risk for a myocardial infarction.

Patent Agency Ranking